Cormedix Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cormedix Inc. on January 16, 2019, covering events occurring on January 14, 2019. The company is incorporated in Delaware and operates from Berkeley Heights, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
On January 14, 2019, Gary Gelbfish, M.D., resigned as a member of the Board of Directors, effective immediately. The resignation was attributed to other commitments and necessities. The company explicitly stated that the departure was not related to any disagreement with the company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed in this report other than the standard disclosure regarding the director's resignation.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following Dr. Gelbfish's immediate resignation.
- Confirm that no other officers or directors have departed or been appointed concurrently.
- Review the attached press release (Exhibit 99.1) for additional context on the resignation.